Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hall MD et al. – When cancer cells develop resistance to chemotherapeutics, it is frequently conferred by the ATP–dependent efflux pump P–glycoprotein. P–gp can efflux a wide range of cancer drugs; its expression confers cross–resistance, termed “multidrug resistance”, to a wide range of drugs. Strategies to overcome this resistance have been actively sought for more than 30 years, yet clinical solutions do not exist. A less understood aspect of MDR is the hypersensitivity of resistant cancer cells to other drugs, a phenomenon known as “collateral sensitivity”.

Related Articles

Changes in Drug Resistance Patterns following the Introduction of HIV Type 1 Non-B Subtypes in Spain
AIDS Research and Human Retroviruses, 10/23/09    Relevance Score: 71%

Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis
The International Journal of Tuberculosis and Lung Disease, 11/20/09    Relevance Score: 69%

Antifungal drug resistance: do molecular methods provide a way forward
Current Opinion in Infectious Diseases, 11/02/09    Relevance Score: 69%

Multiplex PCR-Ligation Detection Reaction assay for the simultaneous detection of drug resistance and toxin genes from Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
Journal of Clinical Microbiology, 10/30/09    Relevance Score: 69%

Drug resistance testing improved survival in HAART-experienced patients
American Pharmacists Association, 10/08/09    Relevance Score: 68%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address